Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 23, 2020
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter studyGiovanni Marasco, Antonio Colecchia, Maria Letizia Bacchi Reggiani, et al.
Hepatology Communications|July 28, 2025
Outcome of hepatic resection for HCC in ideal and non-ideal candidatesLorenzo Lani, Laura Bucci, Valentina Santi, et al.
JHEP Reports : Innovation in Hepatology|July 31, 2023
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programsNicola Reggidori, Laura Bucci, Valentina Santi, et al.
Gut|December 22, 2021
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA databaseAlessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, et al.
Journal of Hepatology|April 9, 2019
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patientsGiuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso, et al.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Hepatology International|March 25, 2025
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinomaAlba Rocco, Costantino Sgamato, Filippo Pelizzaro, et al.
Annals of Surgery|January 26, 2022
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted ComparisonSimone Famularo, Matteo Donadon, Federica Cipriani, et al.
Alimentary Pharmacology & Therapeutics|January 14, 2026
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter StudyElisa Pinto, Filippo Pelizzaro, Vittorio Simeon, et al.
Oncology Research|April 3, 2026
The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and DiabetesAndrea Dalbeni, Marco Vicardi, Leonardo A Natola, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 23, 2020
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter studyGiovanni Marasco, Antonio Colecchia, Maria Letizia Bacchi Reggiani, et al.
Hepatology Communications|July 28, 2025
Outcome of hepatic resection for HCC in ideal and non-ideal candidatesLorenzo Lani, Laura Bucci, Valentina Santi, et al.
JHEP Reports : Innovation in Hepatology|July 31, 2023
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programsNicola Reggidori, Laura Bucci, Valentina Santi, et al.
Gut|December 22, 2021
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA databaseAlessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, et al.
Journal of Hepatology|April 9, 2019
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patientsGiuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso, et al.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Hepatology International|March 25, 2025
Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinomaAlba Rocco, Costantino Sgamato, Filippo Pelizzaro, et al.
Annals of Surgery|January 26, 2022
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted ComparisonSimone Famularo, Matteo Donadon, Federica Cipriani, et al.
Alimentary Pharmacology & Therapeutics|January 14, 2026
Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter StudyElisa Pinto, Filippo Pelizzaro, Vittorio Simeon, et al.
Oncology Research|April 3, 2026
The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and DiabetesAndrea Dalbeni, Marco Vicardi, Leonardo A Natola, et al.
Pageof 21